Rapport Therapeutics Inc (RAPP)

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	20.00	-	-	-
	37.52%60.81	44.22	38.51	29.99	29.50
Selling, General, and Administrative	18.32%9.39	11.50	-	-	-
Research and Development	57.15%51.41	32.72	30.26	22.28	22.68
Operating Income/Loss	151.11%-60.81	-24.22	-38.51	-29.99	-29.50
Nonoperating Income/Loss	3.83%4.19	4.36	4.75	3.06	2.76
	185.11%-56.62	-19.86	-33.76	-26.93	-26.73
Attributable To Parent	185.11%-56.62	-19.86	-33.76	-26.93	-26.73
Available To Common Stockholders, Basic	185.11%-56.62	-19.86	-33.76	-26.93	-26.73
Basic Average Shares	0.50%47.47	47.24	2.71	37.93	35.44
Diluted Average Shares	0.50%47.47	47.24	2.71	37.93	35.44
Basic Earnings Per Share	183.33%-1.19	-0.42	-0.71	-0.71	-0.75
Diluted Earnings Per Share	183.33%-1.19	-0.42	-0.71	-0.71	-0.75